Propel Contour Sinus Implant
FDA premarket approval P100044/S040 · decided 2019-05-31
Approval details
- PMA number
- P100044
- Supplement
- S040
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Propel Contour Sinus Implant
- Generic name
- Drug-eluting sinus stent
- Applicant
- Intersect Ent.
- Date received
- 2019-05-01
- Decision date
- 2019-05-31
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- OWO
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Menlo Park, CA
- Statement
- Change to the in-process acceptance criterion for the mometasone furoate (MF) coating solution assay from a concentration range of 5.9- 6.2 mg/mL to 5.8- 6.1 mg/mL to align with the manufacturing target and lot history data.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| VenSure LightGuide (K212774) | Intersect Ent. | 2022-02-04 |